You are here: Home » PTI Stories » National » News
Business Standard

Datwyler Starts Commercial Production at First Line in Pune, India

Press Trust of India  |  NEW DELHI 

/ -- Datwyler has been expanding its in Pune, India, which now starts commercial production according to First Line standard.

The company participates at this year's CPhI India, which takes place from December 12 to 14 in Greater Noida, Delhi

At booth 14.A04, visitors are introduced to Datwyler's solutions and product portfolio.

Datwyler experts will provide additional information about the company's product portfolio and the extended offering for the Indian market.

From December 12-14, Datwyler, the Swiss-based of state-of-the-art solutions for drug packaging and medical devices, presents its offering at this year's in Greater Noida, Delhi As one of the strongest emerging markets in the global pharma industry, will continue to be of key importance for the company in the future. Therefore, Datwyler started the expansion of the in Pune, about a year ago and has completed it; the plant incorporates the First Line standard and starts commercial production now.

"In the Indian market, Datwyler has been focusing on high-end for products like lyo and serum vials' stoppers, plungers for prefilled syringes and cartridges. With the introduction of the First Line manufacturing concept, the facility now is able to expand its portfolio with the innovative Omni Flex product line to meet the evolving needs in the health care market, especially for the biotech industry," explains Rahul Dev, Vice President India, Datwyler

The offers a platform, where international with over 50,000 representatives from 122+ countries and shape the future of the Indian and South East Asian At booth 14.A04, Datwyler will introduce visitors to its advanced solutions portfolio for the health care industry. Furthermore, visitors will learn more about the First Line and the products which will be produced in the expanded site in Pune, India.

The Powerhouse of the Asian

By leveraging lean production processes, building upon an optimized and entering emerging markets, Datwyler is prepared to master the challenges of the global health care industry. India, as the powerhouse of the Asian pharmaceutical industry, is one of these markets. There are two major reasons why India will continue to be of key importance in the future: the rapid growth and development of the and the countries recognition as one of the global

Datwyler values India as one of its most important markets. The production facility in has been expanded in 2018 incorporating the latest First Line manufacturing standard and about 550 employees that now are working at this facility. An additional area of 24,000 m[2] is available for future growth. This second planned expansion would further double the capacity and could be ready by 2021.

Omni Flex coating: Meets the highest demands for quality and performance

Within the parenteral packaging industry, market trends indicate a growing demand for coated fluoropolymer elastomeric closures, primarily to mitigate risks related to drug stability and compatibility. Due to the negative effects of extractables and leachables on protein structures and ultimately the drugs, many manufacturers of biologics or biosimilars are relying on fluoropolymer elastomeric closure solutions today. The Omni Flex coating is only produced in facilities incorporating the First Line manufacturing standard. This coating is designed to significantly reduce the risk of the medication interacting with the component's material. The lubricious barrier characteristics prevent the need of siliconization, eliminating interaction that could render the drug dangerously or make it ineffective. The Omni Flex coating is applied to a variety of components, including stoppers, plungers and specific small customized designs used in innovative systems. The products which will be now produced in the expanded site in Pune, will be, among others, the V9048 and V9239 serum and compound FM259/0 OF+ 20mm serum stoppers. In addition, the entire non-coated stoppers portfolio, manufactured in alignment with the First Line standard, will be produced in India.

State-of-the-Art - First Line

First Line is specially designed to manufacture for vials and systems in a fully integrated good (GMP) environment. The First Line standard incorporates state-of-the-art clean room technology, automatic production cells, fully automatic camera inspection and a unique washing process. The innovative exceeds the highest quality standards of the European and American regulatory authorities and is certified according to ISO 15378. The implementation of this manufacturing concept in Pune, India allows the expansion of the portfolio with the innovative Omi Flex product line focusing on high-end for products such as plunger stoppers and customized

Datwyler | Health Care

is an international supplier of state-of-the-art industrial components with leading positions in global and regional market segments. As technological leader, delivers added value to its customers in all markets served. Datwyler provides customized to manufacturers and companies which operate in the health care and automotive industry, as well as the market segments civil engineering and consumer goods. Within the health care division, develops, designs and manufactures solutions for injectable packaging and systems to facilitate customers to create a safer medical environment of tomorrow. The recently launched soft dry electrodes are paving the way to an unlimited pipeline of applications in a variety of industries. Looking back onto more than 100 years of history, Datwyler is a reliable partner, now and in the future!

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, December 06 2018. 14:35 IST